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Purpose: Electrospun PLA ﬁber devices were investigated in the form of ﬁber mats and disks.
Metronidazole was used as an active agent; its concentration was 12.2 and 25.7 wt% in the devices.
Methods: The structure was studied by X-ray diffraction and scanning electron microscopy,
drug release by dissolution measurements, while the antimicrobial efﬁciency was tested on ﬁve
bacterial strains.
Results: The XRD study showed that the polymer was partially crystalline in both devices,
but a part of metronidazole precipitated and was in the form of crystals among and within the
ﬁbers. Liquid penetration and dissolution were different in the two devices, they were faster
in disks and slower in ﬁber mats, due to the morphology of the device and the action of
capillary forces. Disks released the drug much faster than ﬁber mats. Although the release
study indicated fast drug dissolution, the concentration achieved a plateau value in 24 hrs for
the disks; the inhibition effect lasted much longer, 13 days for bacteria sensitive to metro-
nidazole. The longer inhibition period could be explained by the slower diffusion of
metronidazole located inside the ﬁbers of the device.
Conclusion: The results suggest that the devices may be effective in the treatment of
periodontitis.
Keywords: drug release devices, ﬁber mats, disks, morphology, dissolution, capillary forces,
diffusion, antimicrobial, inhibition
Introduction
Periodontitis is an inﬂammatory disease resulting from the overgrowth of subgin-
gival polymicrobial community in susceptible hosts affecting the tissues surround-
ing the teeth. The inﬂammation of periodontal tissue causes bone destruction by
osteoclastic resorption together with tissue destruction, and the detachment of
junctional epithelium result in periodontal pocket formation. Conditions in the
periodontal pocket are suitable for bacterial proliferation and result in dysbiosis
owing to a breakdown in host-microbe homeostasis.1,2 This disease is the most
prevalent reason for tooth loss among adults.3
The elimination of bioﬁlm and/or hard deposits (mineralized bioﬁlm) is the
cornerstone of periodontal treatment. The management of periodontal disease
includes the mechanical removal of bioﬁlm with or without the adjunctive use of
systemic antibiotics.4 Systemically administered antibiotics may not be present in
sufﬁcient concentration in the periodontal pocket; therefore, they are often ineffec-
tive, while the common side effects of antimicrobial therapy could occur.5
Numerous publications published in the open literature report investigations on
local delivery systems containing antimicrobial drugs, which – alone or in combination
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with other dental procedures – may result in a more efﬁcient
treatment.5–10 The local administration of delivery systems
with incorporated antibiotics is a promising approach to
treating periodontitis. The introduction of devices containing
antibiotics into the periodontal pockets could result in efﬁ-
cient therapy with limited side effects and reduced risk of
developing drug-resistant microbes. The comparison of local
to systemic drug delivery shows that 100-fold larger concen-
trations of the antimicrobial agents can be achieved at sub-
gingival sites, which can lead to a more efﬁcient therapy.11
Numerous local drug delivery systems such as ﬁbers, strips,
ﬁlms, injectable gels, micro- and nanoparticulate systems,
vesicular systems, and in-situ forming implants were devel-
oped for this purpose during the last decades.5–10
The electrospinning technique has received considerable
attention lately because it is an affordable, cost-effective
and easy-to-use technology for creating nanoﬁbrous scaf-
folds for tissue engineering purposes, as well as drug deliv-
ery systems and wound dressings.12–15 The advantages of
electrospun drug delivery systems are numerous: i) large
drug loading capacity (up to 60%),16 ii) different polymers
may be applied depending on the compatibility of the active
pharmaceutical ingredients, iii) the process is simple and
cost-effective,17 and iv) the modulation of drug release can
be achieved as well.18,19
Sustained drug release can be achieved by both non-
biodegradable and biodegradable polymers. Biodegradable
polyesters such as PLA, polyglycolic acid (PGA), poly
(lactic-co-glycolic) acid (PLGA), and polycaprolactone
(PCL) have already been applied18 for this purpose.
Information about research describing polymer or biopo-
lymer-based electrospun delivery systems containing dif-
ferent antimicrobial agents, which may be applied with
success for the treatment of periodontitis, is available in
the literature.20–25 Fiber mats fabricated using the electro-
spinning method may be suitable for the treatment of
periodontal disease and they could provide prolonged
drug release.20
The goal of the current work was to develop and inves-
tigate locally administrable, PLA-based, metronidazole-
containing devices for the treatment of periodontal disease.
The devices were composed of electrospun ﬁber mats as
received from the spinning process and compressed disks
prepared from the mats. The drug used was metronidazole,
which is known to be an active pharmaceutical ingredient
(API) with an undesirable bitter taste, hindering its local
application as a drug for periodontal treatment. It is
expected that the encapsulation of metronidazole into
a hydrophobic polymer matrix, sustained release, and prob-
ably a lower effective concentration in the oral cavity might
eliminate this problem. We assumed that mats enable the
free ﬂow of the exudate in the periodontal pocket. On the
other hand, disks provide drug delivery devices with
a standardized geometry (surface, width) and equal drug
content and facilitate the treatment of tight pockets.
Accordingly, we analyzed the effect of drug concentration
and the form of the delivery device on the kinetics of drug
release in detail. Practical consequences are brieﬂy men-
tioned in the ﬁnal section of the paper.
Materials and Methods
Materials
Spinning solution was made by dissolving polylactic acid
(PLA) (Ingeo 4032D type, NatureWorks LLC., Minnetonka,
MN, USA) in a mixture of dichloromethane and dimethyl
sulfoxide (Molar Chemicals Ltd., Halásztelek, Hungary). For
the spinning of ﬁbers containing an active agent, metronida-
zole (Ph. Eur. 8., Hungaropharma Plc., Budapest, Hungary)
was also dissolved in the same solvent mixture in different
concentrations.
For in vitro drug diffusion measurements, a pH=7.4
phosphate-buffered saline (PBS) solution was used. The
buffer solution was prepared by dissolving 8 g/dm3 NaCl,
0.2 g/dm3 KCl, 1.44 g/dm3 Na2HPO4 · 2 H2O, and 0.12 g/
dm3 KH2PO4 (Ph. Eur. 8., Hungaropharma Plc., Budapest,
Hungary) in distilled water. The pH was adjusted to 7.4 by
adding an adequate amount of 0.1 M HCl to the solution.
Methods
Fiber Spinning
PLA ﬁbers containing various amounts of metronidazole
were prepared by coelectrospinning, which is a widely
used and cost-effective method to produce nanoﬁbers espe-
cially for tissue engineering and regenerative medicine.26
The ﬁbers were spun at ambient temperature at 15-kV
voltage, 10-cm collector distance, and a feeding rate of
3 cm3/hr. The solvent used was the 80/20 vol% mixture of
dichloromethane and dimethyl sulfoxide. The solution con-
tained the polymer in 10 wt%, while the amount of the
active component was changed from 0 to 3 wt% of the
solution. The random array of ﬁbers was compressed to
disks of 13-mm diameter for further testing.
Sample Preparation
The metronidazole concentration of the ﬁbers was 12.2 and
25.7 wt%, the latter corresponding to the metronidazole
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concentration of the saturated spinning solution. Neat elec-
trospun ﬁbermats taken directly from the aluminum collector
ﬁlm and round-shaped, compressed disks were used for the
analysis of release kinetics and microbial activity. The disks
were obtained by compressing approximately 10–15 mg of
the neat ﬁber under 1 kN pressure for 30 s in a pellet die of
13-mm diameter (Specac Atlas Manual Hydraulic Press 15T
and Specac 13 mm Pellet Press Die, Specac Ltd., Orpington,
Kent, UK).
Scanning Electron Microscopy
The appearance of the disks and ﬁbers and the diameter of the
latter were investigated by scanning electron microscopy
using a Jeol JSM 6380 LA apparatus. The micrographs
were recorded at different magniﬁcations using 15-kVaccel-
eration voltage. Before viewing, the ﬁbers were sputtered
with gold. The determination of ﬁber thickness was done
with the Image Pro Plus 6 software.
X-Ray Diffraction Analysis
A Bruker D8 Advance diffractometer (Bruker AXS GmbH,
Karlsruhe, Germany) with CuKα radiation (λ = 1.5406 Å)
was used for the XRD analysis. The samples were scanned
at 40 kV and 20 mA from 3° to 40° 2θ angle at a scanning
rate of 0.1 °/s and a step size of 0.01°.
Penetration of the Aqueous Medium, Wetting
The behavior of the devices in contact with water was
studied with an OCA Contact Angle System (Dataphysics
OCA 20, Dataphysics Inc., GmbH, Germany). The contact
angle of water droplets was determined on the neat electro-
spun ﬁbers, the disks prepared from them as described
above, and on a metronidazole pastille of the same size.
The measurement was done with a water droplet of 10 μL
volume, which was dropped from a calibrated syringe onto
the surface of the various devices. Contact angle was mea-
sured instantly after the placement of the droplet, as well as
10 and 20 mins afterward. Five parallel measurements were
done on each sample.
In vitro Drug Release Study
The in vitro drug release proﬁles of the nanoﬁbers were
determined by the measurement of dissolution followed
by UV-Vis spectroscopy. Disks (0.014–0.017 g) and neat
ﬁber mats (0.012–0.016 g) were weighed and put into
7.5 mL of pH=7.4 PBS solution thermostated at 37°C.
Samples of 1.0 mL volume were taken at 0.5, 1, 4, 6, 10,
24, 30, 48, 72, 96, and 196 hrs and replaced with 1.0 mL
of fresh PBS solution. Drug release was followed for 7
days. The concentration of the released metronidazole
was determined by UV-Vis spectrophotometry (Helios α
Thermospectronic UV-spectrophotometer v4.55, Unicam:
Thermo Fisher Scientiﬁc, Waltham, MA) at 318 nm.
Blank samples (PLA ﬁber mats and disks) were also
treated in the same way as reference, but in their case
no absorbance was detected in the wavelength range of
200–900 nm with spectrophotometric analysis.
Antimicrobial Test
The antibacterial efﬁciency of the disks containing 12.2 or
25.7 wt% metronidazole was determined as well. The
control strains of ﬁve bacteria were used in the study:
Fusobacterium nucleatum (ATCC® 25586™), Parvimonas
micra (ATCC 33270™), Eikenella corrodens (ATCC
23834™), Aggregatibacter actinomycetemcomitans (ATCC
29524™), and Prevotella intermedia (118710). All measure-
ments were carried out according to the same protocol.
A bacterial suspension of one McFarland standard concentra-
tion, which is equivalent to approximately 3×108 colony-
forming units/mL in the suspension, was freshly prepared
with normal saline solution. Equivalent portions of the suspen-
sions were then spread onto a horse blood agar plate and disks
of equal weight were placed on it. The diameter of the inhibi-
tion zone was measured after 24 hrs of incubation in an
anaerobic chamber. The disks were then put again on a new
horse blood agar plate, also inoculated with a bacterial suspen-
sion of one McFarland standard concentration freshly made
from the bacterial strains mentioned above. The plates were
then put into an anaerobic chamber for 24 hrs. The procedure
was repeated until no inhibition zone could be detected, or for
a maximum of 14 days. Three parallel measurements were
carried out for every formulation and bacterial strain.
Statistical Analysis
The results of the in vitro drug release study were analyzed
statistically with GraphPad Prism version 5 software. Two-
way ANOVA analysis was used with Bonferroni post-tests.
A level of p ≤ 0.05 was considered as signiﬁcant, p ≤ 0.01 as
very signiﬁcant, and p ≤ 0.001 as highly signiﬁcant.
Results and Discussion
The results are discussed in several sections. First, results
related to the structure of the devices are presented and
then the penetration of the dissolution medium into them is
analyzed. Drug release and the results of the microbiolo-
gical testing are discussed in the last two sections together
with a few remarks on practical relevance.
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Structure
PLA has a regular molecular structure and can crystallize
under appropriate conditions, and metronidazole is also
a crystalline material. The solubility of the drug in the poly-
mer and its diffusion into the surrounding medium depend
on the structure of the components and on their distribution.
Metronidazole is a water-soluble, polar substance, the solu-
bility of which is small in the polymer. Accordingly, some of
the drugs can be dissolved, but another part precipitates and
is located among or inside the ﬁbers as crystals. Structure
determines drug release and its control allows the regulation
of efﬁciency through modiﬁed drug release.
The structure was studied by XRD analysis and SEM
microscopy. The crystallization of PLA is slow; thus,
products prepared from this polymer are usually amor-
phous. On the other hand, the evaporation rate and the
possible presence of residual solvent might result in the
crystallization of the polymer. The XRD study showed that
the ﬁbers were partially crystalline at the time of the
measurements and the release, as well as during the micro-
biological measurements. As expected, the compression of
the mat into disc did not change the structure.
The incorporation of metronidazole may change the
structure of the polymer. The drug may act as a nucleating
agent, but it can change the rate of crystallization as well. The
XRD traces of metronidazole and those of the ﬁber mat
containing 12.2 and 25.7 wt% of the drug are presented in
Figure 1. The characteristic reﬂections of metronidazole can
be detected in the traces and their intensity increases with
increasing concentration. Obviously, not the entire amount of
the drug added to the spinning solution is dissolved in the
polymer, but it precipitates during ﬁber spinning and is dis-
persed in crystalline form among and/or inside the ﬁbers. The
location and physical form of metronidazole may inﬂuence
drug release signiﬁcantly, thus determining both the efﬁ-
ciency of the device and its lifetime, the length of the active
period.
The XRD traces of disks containing 25.7 wt% metroni-
dazole are presented in Figure 2 before and after drug release
(dissolution). The intensity of characteristic peaks belonging
to metronidazole decreases during the dissolution experiment
as an effect of drug release. It can also be seen that some
metronidazole remains in the device even after the dissolution
experiment, which conﬁrms our earlier assumption that some
of the drug precipitates during ﬁber spinning and crystals are
located not only among, but also within the ﬁbers. The release
of this latter part of the drug is quite slow and does not take
place in the timescale of the dissolution experiment.
The structure of the ﬁber mat and the disks was also
studied by scanning electron microscopy. Micrographs
showing the differences in structure are presented in
Figure 3. The mat consists of loose ﬁbers with considerable
space among individual ﬁbers (Figure 3A). One would
expect fast penetration and easy ﬂow of the ﬂuid used for
dissolution and thus very fast release of the drug. The
scrutiny of micrographs recorded on mats reveals the pre-
sence of metronidazole crystals among the ﬁbers. The struc-
ture of a disk is shown in the micrograph of Figure 3B. The
disk has a much more compact structure, voids are smaller,
and the ﬁbers are close to each other. The presence of
5 10 15 20 25 30 35
c)
b)
).u.a(
ytisnetnI
Angle of reflection, 2  (°)
12.2 wt% drug
25.7 wt%
a)
Figure 1 Inﬂuence of metronidazole content on the structure of PLA ﬁber mats,
where: a) neat metronidazole, b) 12.2 wt%, and c) 25.7 wt% drug.
5 10 15 20 25 30 35
).u.a(
ytisnetnI
Angle of reflection, 2  (°)
a)
b)
Figure 2 Effect of the dissolution of the drug on the structure of disks prepared
from electrospun ﬁbers by compression. Metronidazole content: 25.7 wt%. a)
before and b) after the dissolution experiment.
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metronidazole crystals among the ﬁbers is more obvious in
this case. The SEM study veriﬁed the conclusions drawn
from the XRD measurements and proves that a part of the
drug is distributed in crystal form among and probably also
within the ﬁbers.
Penetration of the Aqueous Medium,
Wetting
In order to obtain some idea about the penetration of the
dissolution medium into the devices prepared, the contact
angle of water was measured on them as a function of time.
The results are presented in Table 1. Interpretation is difﬁcult
because of the complexity of the system and the related
processes. Contact angle is usually measured by placing
a droplet of a liquid onto a smooth, stable surface. In our
case, the surface used for the measurement is neither stable
nor smooth. Metronidazole dissolves in water, while both
the ﬁber mats and the compressed disks have rough, porous
surfaces (see Figure 3) into which the liquid may penetrate.
Accordingly, the contact angle measured depends on the rate
of dissolution in the case of metronidazole, and on surface
tension and surface morphology in the case of the two
devices. Pore size and capillary forces also play an important
role in the determination of the value of the contact angle,
but also in drug release. Since the surface tension of the
components is constant and we do not expect large changes
in the surface tension of PLA as an effect of the dissolution
of some metronidazole, the major factors must be morphol-
ogy, porosity, and capillary forces.
According to the results of Table 1, the contact angle of
water on the metronidazole pastille is small, which is not
very surprising since metronidazole dissolves in water.
Dissolution is conﬁrmed by the fact that the contact
angle could not be measured after 10 mins of forming
the droplet. Contrary to metronidazole, the contact angle
of the droplet placed onto the ﬁber mat is quite large,
indicating poor wetting and penetration. Contact angle
does not change with metronidazole content; the differ-
ences are caused by changes in morphology and the stan-
dard deviation of the measurements. Contact angles
showed just a slight systematic decrease with time for
the neat ﬁber mats, indicating that water can slowly pene-
trate into the mat.
The contact angle measured on the compressed disks is
much smaller and it is independent of the concentration of
metronidazole as well. It decreases considerably with time
and could not be measured after 10 mins at all, showing
that the water droplet placed onto the disk disappeared in
this time interval. The difference in the contact angles
measured on the ﬁber mat and the compressed disk proves
A
B
Figure 3 SEM micrographs recorded on the PLA devices studied. A) ﬁber mat, B)
compressed disk. The black dots are crystalline metronidazole particles in Figure 3B.
Table 1 Contact Angles Measured (Mean and SD Values) on
a Metronidazole Pastille and on Drug Release Devices (Fiber
Mats, Disks) at Various Times
Device Drug
Content
(wt%)
Contact Angle (°) After Time (Min)
0 10 20
MZ pastille 100 32.5 ± 1.8 – –
Fiber mat 0 125.3 ± 3.8 123.2 ± 4.0 121.4 ± 0.8
12.2 110.8 ± 3.1 104.6 ± 5.3 96.0 ± 8.9
25.7 117.3 ± 7.2 112.3 ± 9.5 105.8 ± 12.2
Disk 0 62.5 ± 1.6 48.7 ± 0.5 –
12.2 66.9 ± 1.4 46.4 ± 0.3 –
25.7 64.3 ± 0.5 47.0 ± 0.2 –
Dovepress Budai-Szűcs et al
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that the primary factor determining aqueous media pene-
tration is morphology and this factor is expected to deter-
mine the extent and rate of drug release as well.
The apparent contradiction that water cannot penetrate
so fast into the loose ﬁber mats, while it does into the
discs, should be considered. Capillary forces depend on
the interaction of the liquid and the capillary and also on
the size of the capillary, i.e., on pore size, in our case.
Water climbs in a glass capillary, but the level of mercury
decreases in it. The surface tension of water is 72 mJ/m2,
while that of mercury is 486 mJ/m2; thus, the ﬁrst wets
glass, while the other does not. In our case, the surface
tension of water is still the same (72 mJ/m2) as mentioned
above and that of PLA is around 40 mJ/m2.27–29
Accordingly, water does not wet PLA ﬁbers and cannot
penetrate into the devices easily. Compression obviously
changed the pore structure of the device (see Figure 3),
which decreases capillary forces and helps penetration. As
an effect of changing morphology and penetration, we may
expect a faster release of the drug from the disk than from
the ﬁber mat.
In vitro Drug Release
The release of the drug incorporated into the devices
prepared from electrospun ﬁbers is a complex process
and depends on several factors. As the results of the
XRD measurements (Figures 1 and 2) and the SEM micro-
graphs (Figure 3) showed the drug, metronidazole in this
case, is incorporated into the devices in various forms: as
precipitated crystals within and among the ﬁbers and as
dissolved molecules in PLA. The dissolution of these
forms must be different. The PBS solution must penetrate
the device, dissolve the crystals and diffuse out into the
surrounding medium. On the other hand, dissolved metro-
nidazole must diffuse out of the PLA ﬁbers into the sur-
rounding medium. The solubility of metronidazole is small
in PLA, and diffusion is driven by concentration differ-
ence, which is also small or even negative due to the large
drug concentration of the surrounding solution because of
the dissolution of the crystals. Consequently, the main
factor determining the dissolution of metronidazole from
the devices, i.e., drug release, is the penetration and ﬂow
of the PBS solution. This is different for the two devices,
mats and disks; thus dissimilar drug release is expected
from them.
The time dependence of dissolution is presented in
Figure 4 for the ﬁber mats and the disks at two different
concentrations. In view of the observations presented
in Section 3.2, some of the results were expected.
Compressed disks release the drug much faster than ﬁber
mats because of the larger and faster penetration of the
aqueous medium into the pores of the device. However,
the fact that dissolution is independent of the initial con-
centration of metronidazole in the device is somewhat
surprising. The fast penetration and dissolution of metroni-
dazole in the PBS solution can result in the independence of
concentration. The diffusion of the liquid containing the
dissolved drug into the surrounding medium may be the
rate-determining step of dissolution in this case.
In the case of the ﬁber mats, the rate of dissolution
depends on concentration, however, not as expected, i.e.,
faster rate at larger concentration, but in the opposite
way. The slower release of the drug from the mats can
be understood easily if we consider the difference in the
penetration of the aqueous medium (see Table 1). The
effect of concentration, on the other hand, is difﬁcult to
explain. Obviously, the dissolution of the drug in the
PBS solution and its diffusion into the surrounding
medium are the rate-determining steps in this case.
However, the presence of the drug cannot inﬂuence the
diffusion rate much; thus, dissolution must be dissimilar
at the two concentrations of metronidazole. The larger
drug concentration probably results in larger precipitated
crystals, which leads to slower dissolution and release.
0 30 60 90 120 150 180 210
0
20
40
60
80
100
120
)
%(
elozadinorte
m
devlossi
D
Time (hour)
Figure 4 Dissolution of metronidazole from ﬁber mats and disks. Effect of drug
content. Symbols: (□,■) 12.2 wt%, (○,●) 25.7 wt% metronidazole; empty symbols:
ﬁber mat, full symbol: disk; solid lines are ﬁtted functions, while the broken line
shows the two-step process.
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The rate of dissolution can be estimated qualitatively
from the correlations presented in Figure 4. According to
this evaluation, plateau concentrations are reached after 24
hrs for the disks, and after 48 or 96 hrs for the ﬁber mats.
However, time dependence can be evaluated quantitatively if
appropriate functions are ﬁtted to the experimental data. The
dissolution and the diffusion of the drug are determined by
Fick’s laws. Fick’s equations can be solved numerically or
they can be expressed analytically using simpliﬁcations.30
Two main approaches are used in practice, those describing
the ﬁrst part of the function plotting experimental results as
the function of the square root of time, or those which use an
exponential function. This approach gives a more accurate
estimate at long times and it allows the estimation of the
overall rate of dissolution and the maximum amount of
dissolved material at inﬁnite time (if the shape and structure
of the device do not change, e.g.: ﬁber degradation). We
followed the latter approach and ﬁtted the function of
Equation 1 to the experimental results:
Mt ¼ M1 1 8
π2
exp atð Þ þ 1
9
exp 9atð Þ þ 1
25
exp 25atð Þ
  
(1)
where Mt and M∞ are the dissolved amount of drug at time
t and at inﬁnite time, respectively, and a is the overall rate
of dissolution. The ﬁtted functions are presented in Figure 4
as solid lines. The parameters calculated from the ﬁtting are
collected in Table 2.
Results presented in Table 2 conﬁrm our qualitative
evaluation and show that dissolution is much faster from
the disk than from the ﬁber mat (see parameter a). It also
conﬁrms the composition dependence observed. The com-
parison of the predicted amount of drug dissolved at inﬁ-
nite time (M∞) indicates that a considerable amount of
drug, 10–30% remains in the devices after the dissolution
experiment even in the case of the disks. Moreover,
a closer comparison of the ﬁtted lines and the measured
values indicates that dissolution cannot be described with
a single process; it consists of at least two steps, a faster
one at the beginning of the experiment and another one
proceeding at a slower rate. This two-step process is
demonstrated especially well by the results obtained on
the ﬁber mat containing 25.7 wt% metronidazole (see Δ
series in Figure 4). The two steps demonstrated by the
broken line in the ﬁgure might be explained by the dis-
solution of the different forms of the drug; crystals located
among the ﬁbers dissolve much faster than dissolved
metronidazole or crystals precipitated within the ﬁbers.
In this case, signiﬁcant differences could be observed
(from 2.5 to 6 hrs: p ≤ 0.001; from 6 to 30 hrs: p ≤ 0.01;
and from 30 to 72 hrs: p ≤ 0.05) between the drug release
of ﬁber mats and disks. The different rates allow the
regulation of the amount of the drug as a function of
time and also the active lifetime of the device.
Controlling the form of the drug in the device and the
rate of water diffusion into the electrospun porous ﬁber
network might be an efﬁcient strategy to control drug
release.31,32
Antimicrobial Activity
The oral cavity and/or various dental surfaces may be inhab-
ited by numerous strains of pathogen bacteria. Personal fea-
tures, dietary habits, or even habitation could have an inﬂuence
on the composition of the oral microbiota.33,34 The contribu-
tion of different bacterial strains to the initiation and progres-
sion of periodontitis is under serious investigation.33–41
However, the task seems to be almost impossible because of
the large number of various microorganism species, difﬁcul-
ties of cultivation, and the fact that only a small part of the
bacteria present in the subgingival cavity could be linked to the
pathogenesis of the disease.42 Pathogens playing a role in the
formation and progression of periodontal disease can be sub-
divided into three groups. The ﬁrst category strains are able to
stick to dental surfaces, the bacteria in the second group form
a bridge between the ﬁrst and the third category, while the
bacteria of the third group are responsible for bacterial bioﬁlm
formation (Socransky and Haffajee, 2002). The following
strains may initiate disease formation: Porphyromonas
gingivalis, P. intermedia, Bacteroides forsythus, A. actinom-
ycetemcomitans, Treponema denticola, Tannerella forsythia,
F. nucleatum, Fusobacterium periodonticum, Prevotella
nigrescens, P. micra, Campylobacter gracilis, Campylo-
bacter rectus, Campylobacter showae, Eubacterium nodatum,
Streptococcus constellatus, E. corrodens, Streptococcusspp.,
etc.33,42–44
Only disks were included in the microbiological study, as
uniform shape, weight, and thickness could not have been
Table 2 Parameters Characterizing the Kinetics of Dissolution
Determined by Fitting Equation 1 to the Experimental Results
Drug Content (wt%) Form a (1/hr) M∞ (%) R
2a
12.2 Mat 0.233 81.9 0.8855
25.7 Mat 0.051 71.8 0.9634
12.2 Disk 0.581 89.4 0.9449
25.7 Disk 0.556 89.1 0.9650
Notes: aDetermination coefﬁcient showing the goodness of the ﬁt.
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achieved with the ﬁber mats. The delivery systems evaluated
contained 12.2 and 25.7 wt% metronidazole. Five different
bacterial strains were used in this investigation: E. corrodens,
P. intermedia, P. micra, F. nucleatum, and A. actinomycete-
mcomitans. E. corrodens is a facultative anaerobic, gram-
negative bacterium and a human (mostly oral) pathogen.
E. corrodens is reported to be unsusceptible to metronid-
azole.45 P. micra is a gram-positive, anaerobic coccus and
part of the normal human gastrointestinal ﬂora.46 Literature
data suggest that this strain is not susceptible to metronida-
zole either.47 P. intermedia is a black pigmented, gram-
negative anaerobic bacterium. It is often connected with
oral and subgingival diseases. Metronidazole is efﬁcient
against P. intermedia.48 F. nucleatum, which is a mostly
oral and periodontal anaerobic pathogen bacterium, can be
related to several human diseases. This strain seems to be
sensitive to metronidazole.49,50
A facultatively anaerobic gram-negative bacterium,
A. actinomycetemcomitans, can often be linked to period-
ontal disease and oral infections. Susceptibility to metro-
nidazole is reported to be weak.51,52
The results of the microbiological study are presented
in Figure 5. The duration of the antimicrobial effect is
apparently independent of concentration; it is the same
for disks with 12.2 and 25.7 wt% metronidazole content
in most cases. A one-day difference appeared in growth
inhibition for P. micra at 12.2 and 25.7 wt% metronidazole
contents. In the other cases, disks with a larger metroni-
dazole content provided slightly larger inhibition zones
than systems containing less drug on most days.
Bacterial growth inhibition is shorter, only 2–3 days for
A. actinomycetemcomitans, E. corrodens and P. micra,
while the growth of F. nucleatum and P. intermedia was
affected for a longer time, for 13 days.
The results of our measurements agree well with those
published in the literature, suggesting that F. nucleatum and
P. intermedia are more susceptible to metronidazole than
A. actinomycetemcomitans, E. corrodens and P. micra,
which may be completely resistant or minimally sensitive
to the antimicrobial drug used. The diameter of the inhibi-
tion zone increases slightly with increasing metronidazole
concentration, probably because of longer diffusion paths
resulting in enhanced inhibition. The differences in the
diameter of the inhibition zone are more pronounced for
strains with larger susceptibility to metronidazole and they
increase with time as well. Inhibition was observed in the
growth of susceptible bacteria for as long as almost 2
weeks, indicating that our devices can be efﬁcient for
a long time. This fact, however, needs some consideration,
since the dissolution study indicated that most of the drug is
released from the disks in 24 hrs. The contradiction might
be explained by the difference in the conditions, but also in
the presence of metronidazole located within the polymer in
the form of dissolved molecules or precipitated crystals.
The diffusion, thus the release rate of metronidazole is
much slower in this latter case than for the drug located
among the ﬁbers in crystal form. A slower rate leads to
prolonged inhibition times, which could result in greater
patient compliance and better results of the periodontitis
treatment.
Conclusion
The XRD study of drug release devices prepared from
electrospun PLA ﬁbers showed that the polymer was par-
tially crystalline in both devices, i.e., in ﬁber mats and
disks. A part of metronidazole precipitated and was located
in the form of crystals among the ﬁbers. The penetration of
the aqueous medium and dissolution were different in the
two devices, they were faster in disks and slower in ﬁber
mats, due to the morphology of the device and because of
the action of capillary forces. Disks released the drug much
faster than ﬁber mats. The microbiological study carried out
with ﬁve bacterial strains conﬁrmed results published in the
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Figure 5 Inhibition zones (mean and SD values) developing in the presence of
different anaerobic pathogen bacteria of the oral cavity using disks, which contain
various amounts of metronidazole. Symbols: (○) P. intermedia, (□) F. nucleatum, (Δ)
A. actinomycetemcomitans, (∇) P. micra, (◊) E. corrodens; empty symbol: 12.2 wt%, full
symbol: 25.7 wt% metronidazole.
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open literature that some strains are insensitive to metroni-
dazole (A. actinomycetemcomitans, E. corrodens, P. micra),
while the drug is very efﬁcient against others (F. nucleatum,
P. intermedia). Although the release study indicated the fast
dissolution of the drug, the concentration achieved a plateau
value in 24 hrs for the disks; the inhibition effect was much
longer, 13 days for bacteria sensitive to metronidazole. The
longer inhibition period could be explained by the slower
diffusion of metronidazole located inside the ﬁbers of the
devices and the slow penetration of the aqueous medium
into them. The results indicated that in all probability the
devices prepared may be effective in the treatment of
periodontitis.
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